Product image of Cefotaxime Swyssi (Cefotaxime) supplied by GNH India

Cefotaxime Swyssi

Active Ingredient:
Cefotaxime
Origin:
EU

Cefotaxime Swyssi (Cefotaxime)

Cefotaxime Swyssi is a parenteral antibiotic used to treat bacterial infections. This broad-spectrum medication is manufactured by Swyssi Ag in the EU.

Manufacturer / TM Owner

Swyssi Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cefotaxime Swyssi is primarily used for the treatment of various bacterial infections. It is often administered when oral antibiotics are not suitable, targeting a wide range of bacteria. This medication is commonly prescribed for infections in the respiratory tract, urinary tract, and skin, among others. Patients often ask, 'What is Cefotaxime used for?' and the answer lies in its broad-spectrum capabilities.

Side Effects

  • Common effects of Cefotaxime Swyssi may include mild to moderate reactions at the injection site, such as redness or swelling. Some patients may experience gastrointestinal discomfort or allergic reactions. These effects are generally temporary and should be monitored closely.

Precautions & Warnings

  • Cefotaxime Swyssi should be handled with care, ensuring proper sterile techniques during administration. Patients with known allergies to cephalosporins should consult their healthcare provider before use. It is important to follow the prescribed guidelines for parenteral use to minimize risks.

Avoid Interactions

  • Cefotaxime Swyssi may interact with certain medications, including other antibiotics and blood thinners. Alcohol consumption should be avoided as it can exacerbate side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Cefotaxime Swyssi is used to treat a variety of bacterial infections, particularly when oral antibiotics are not effective.

Cefotaxime Swyssi is administered parenterally, typically through injection or infusion, under medical supervision.

Common side effects may include reactions at the injection site, gastrointestinal discomfort, and allergic reactions.

Cefotaxime Swyssi may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Patients with known allergies to cephalosporins or those with severe kidney or liver impairment should consult their healthcare provider before using Cefotaxime Swyssi.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cefotaxime

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT